- BridgeBio adds $1B as it prepares three more drug launchesBridgeBio Pharma has reloaded with about $1 billion in a preferred equity deal to bolster its reserves ahead of three potential drug launches over the next year. The California biotech, which for…Endpoints · 25d ago↗ source
- STAT+: Synthetic biology researchers think they’ve made a cell. Is it alive?Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece…STAT · 25d ago↗ source
- STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and moreAnthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs and by drugmakers